Sitagliptin (MK0431)

DRUG3 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Diabetes Mellitus, Type 2Diabetes Mellitus, Type II

Phase 3

Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)

CompletedNCT00086515

Merck Sharp & Dohme LLCDiabetes Mellitus, Type II

Start: 2004-06-30End: 2007-02-02Updated: 2017-05-05

Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)

CompletedNCT00087516

Merck Sharp & Dohme LLCDiabetes Mellitus, Type 2

Start: 2004-06-30End: 2007-02-28Updated: 2015-07-03

An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)

CompletedNCT00094770

Merck Sharp & Dohme LLCDiabetes Mellitus, Type 2

Start: 2004-09-30End: 2007-05-31Updated: 2016-08-26

Related Papers

Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial.

2017-05-1516 citations

Comparison of treatment with sitagliptin or sulfonylurea in patients with type 2 diabetes mellitus and mild renal impairment: a post hoc analysis of clinical trials.

2015-01-307 citations

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01